Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 18, 2023

BUY
$2.46 - $3.14 $77,349 - $98,731
31,443 New
31,443 $78,000
Q2 2022

Jul 25, 2022

SELL
$4.04 - $8.51 $62,110 - $130,832
-15,374 Closed
0 $0
Q1 2022

May 02, 2022

SELL
$7.6 - $11.02 $30,688 - $44,498
-4,038 Reduced 20.8%
15,374 $116,000
Q4 2021

Jan 28, 2022

BUY
$10.16 - $16.17 $197,225 - $313,892
19,412 New
19,412 $198,000

Others Institutions Holding GTHX

About G1 Therapeutics, Inc.


  • Ticker GTHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,746,800
  • Market Cap $306M
  • Description
  • G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...
More about GTHX
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.